Benjamin Burnett
Stock Analyst at Stifel
(2.14)
# 2,799
Out of 4,761 analysts
68
Total ratings
42.55%
Success rate
-3.81%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Benjamin Burnett
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRSP CRISPR Therapeutics AG | Maintains: Hold | $53 → $49 | $47.91 | +2.28% | 6 | Feb 13, 2025 | |
| IRON Disc Medicine | Maintains: Buy | $90 → $94 | $54.53 | +72.38% | 7 | Jan 24, 2025 | |
| RPTX Repare Therapeutics | Maintains: Buy | $9 → $4 | $1.29 | +210.08% | 5 | Dec 13, 2024 | |
| ACLX Arcellx | Maintains: Buy | $83 → $122 | $63.75 | +91.37% | 5 | Oct 18, 2024 | |
| BEAM Beam Therapeutics | Maintains: Buy | $66 → $69 | $30.43 | +126.75% | 2 | Sep 11, 2024 | |
| IDYA IDEAYA Biosciences | Maintains: Buy | $63 → $68 | $21.85 | +211.21% | 7 | Sep 10, 2024 | |
| PGEN Precigen | Maintains: Buy | $7 → $10 | $1.91 | +423.56% | 3 | Jun 3, 2024 | |
| ALLO Allogene Therapeutics | Maintains: Hold | $4.4 → $4.6 | $2.17 | +111.98% | 5 | May 14, 2024 | |
| ATRA Atara Biotherapeutics | Maintains: Hold | $120 → $58 | $7.11 | +708.72% | 4 | Apr 1, 2024 | |
| RVMD Revolution Medicines | Maintains: Buy | $37 → $47 | $41.34 | +13.69% | 3 | Sep 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $5.78 | +332.53% | 11 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $5.3 → $5 | $1.42 | +252.11% | 2 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $690 → $780 | $5.93 | +13,053.46% | 2 | Sep 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $22 → $24 | $0.93 | +2,474.55% | 2 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $16 | $1.07 | +1,395.33% | 1 | Jan 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $1,880 → $1,400 | $4.08 | +34,213.73% | 3 | Mar 27, 2020 |
CRISPR Therapeutics AG
Feb 13, 2025
Maintains: Hold
Price Target: $53 → $49
Current: $47.91
Upside: +2.28%
Disc Medicine
Jan 24, 2025
Maintains: Buy
Price Target: $90 → $94
Current: $54.53
Upside: +72.38%
Repare Therapeutics
Dec 13, 2024
Maintains: Buy
Price Target: $9 → $4
Current: $1.29
Upside: +210.08%
Arcellx
Oct 18, 2024
Maintains: Buy
Price Target: $83 → $122
Current: $63.75
Upside: +91.37%
Beam Therapeutics
Sep 11, 2024
Maintains: Buy
Price Target: $66 → $69
Current: $30.43
Upside: +126.75%
IDEAYA Biosciences
Sep 10, 2024
Maintains: Buy
Price Target: $63 → $68
Current: $21.85
Upside: +211.21%
Precigen
Jun 3, 2024
Maintains: Buy
Price Target: $7 → $10
Current: $1.91
Upside: +423.56%
Allogene Therapeutics
May 14, 2024
Maintains: Hold
Price Target: $4.4 → $4.6
Current: $2.17
Upside: +111.98%
Atara Biotherapeutics
Apr 1, 2024
Maintains: Hold
Price Target: $120 → $58
Current: $7.11
Upside: +708.72%
Revolution Medicines
Sep 21, 2023
Maintains: Buy
Price Target: $37 → $47
Current: $41.34
Upside: +13.69%
Sep 15, 2023
Reiterates: Buy
Price Target: $25
Current: $5.78
Upside: +332.53%
May 4, 2023
Maintains: Hold
Price Target: $5.3 → $5
Current: $1.42
Upside: +252.11%
Sep 10, 2021
Maintains: Buy
Price Target: $690 → $780
Current: $5.93
Upside: +13,053.46%
Jun 28, 2021
Upgrades: Buy
Price Target: $22 → $24
Current: $0.93
Upside: +2,474.55%
Jan 6, 2021
Initiates: Hold
Price Target: $16
Current: $1.07
Upside: +1,395.33%
Mar 27, 2020
Upgrades: Buy
Price Target: $1,880 → $1,400
Current: $4.08
Upside: +34,213.73%